Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Oncology GroupSumit Gupta, Meenakshi Devidas, Wanda L. Salzer et al.|Journal of Clinical Oncology|2020Cited by 190
Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trialsMichael J. Burke, Archie Bleyer, Meenakshi Devidas et al.|Leukemia & lymphoma/Leukemia and lymphoma|2017Cited by 46